SQI Diagnostics, Inc. develops rapid diagnostic tests utilizing proprietary technology for organ transplant, autoimmune disease, and COVID-19 detection. Their products include direct-to-consumer antibody tests and point-of-care triage tests, providing healthcare providers and patients with timely and accurate results to inform treatment decisions.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional diagnostic testing for organ transplant monitoring, autoimmune diseases, and infectious diseases often suffers from slow turnaround times and limited accessibility, hindering timely clinical decision-making. Existing methods may require specialized laboratory equipment and trained personnel, creating bottlenecks in healthcare delivery.
Solution
SQI Diagnostics develops and commercializes rapid diagnostic tests designed for point-of-care and direct-to-consumer applications. These tests leverage proprietary technology to deliver fast, accurate results for organ transplant assessment, autoimmune disorder diagnosis, and infectious disease detection, including COVID-19. By providing actionable information at the point of need, SQI Diagnostics enables healthcare providers and individuals to make informed decisions, optimize treatment strategies, and improve patient outcomes. The company's focus on rapid, accessible diagnostics aims to streamline healthcare workflows and enhance the overall efficiency of disease management.
Target Audience
The primary target audience includes healthcare providers (physicians, nurses, transplant centers), clinical laboratories, and individual consumers seeking convenient and timely diagnostic information.
Features
- Rapid diagnostic assays for organ transplant monitoring, autoimmune disease diagnosis, and infectious disease detection
- Point-of-care testing format for immediate results and decentralized access
- Direct-to-consumer testing options for convenient at-home use
- Proprietary technology platform for enhanced sensitivity and specificity